Radiopharm Theranostics Files June 2025 6-K Report
Ticker: RDPTF · Form: 6-K · Filed: Jun 12, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
Radiopharm Theranostics filed its June 6-K, confirming 20-F filing and Australian HQ.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on June 12, 2025, reporting information for the month of June 2025. The filing indicates the company is a foreign private issuer and will file its annual reports under cover of Form 20-F. The company's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Why It Matters
This filing provides routine updates for investors and regulators regarding Radiopharm Theranostics' status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (company) — Principal executive office address
- June 2025 (date) — Reporting period
- 20250612 (date) — Filing date
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2025.
Under which form will Radiopharm Theranostics Limited file its annual reports?
Radiopharm Theranostics Limited will file its annual reports under cover of Form 20-F.
What is the principal executive office address of Radiopharm Theranostics Limited?
The principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Is Radiopharm Theranostics Limited furnishing information under Rule 12g3-2(b)?
No, the company has indicated it is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
What is the SEC file number for Radiopharm Theranostics Limited?
The SEC file number for Radiopharm Theranostics Limited is 001-41621.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 12, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).